Brief: Caliway Announced EMA Orphan Drug Designation Granted To CBL-514 For Dercum's Disease Treatment

Caliway Biopharmaceuticals Co

12/11/2024 13:33

Nov 12 (Reuters) - Caliway Biopharmaceuticals Co Ltd
 6919.TW :
    * CALIWAY ANNOUNCED EMA ORPHAN DRUG DESIGNATION GRANTED TO
CBL-514
FOR DERCUM'S DISEASE TREATMENT

Source text:  ID:nPncbMKSpa 
Further company coverage:  6919.TW 

 ((Reuters.Briefs@thomsonreuters.com;))